Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cefepime monotherapy for febrile neutropenia in patients with lung cancer.
Saito H, Takahashi K, Okuno M, Saka H, Imaizumi K, Hasegawa Y, Tanikawa Y, Yamamoto M, Taniguchi H, Shindoh J, Suzuki R, Shimokata K; Central Japan Lung Study Group. Saito H, et al. Among authors: yamamoto m. J Infect Chemother. 2014 Jun;20(6):365-9. doi: 10.1016/j.jiac.2014.02.002. Epub 2014 Mar 26. J Infect Chemother. 2014. PMID: 24679653 Clinical Trial.
Sequence effect of docetaxel and carboplatin on toxicity, tumor response and pharmacokinetics in non-small-cell lung cancer patients: a phase I study of two sequences.
Ando M, Saka H, Ando Y, Minami H, Kuzuya T, Yamamoto M, Watanabe A, Sakai S, Shimokata K, Hasegawa Y. Ando M, et al. Among authors: yamamoto m. Cancer Chemother Pharmacol. 2005 Jun;55(6):552-8. doi: 10.1007/s00280-004-0921-z. Epub 2005 Mar 15. Cancer Chemother Pharmacol. 2005. PMID: 15856233 Clinical Trial.
A phase II study of carboplatin and paclitacel with meloxicam.
Suzuki R, Yamamoto M, Saka H, Taniguchi H, Shindoh J, Tanikawa Y, Nomura F, Gonda H, Imaizumi K, Hasegawa Y, Shimokata K. Suzuki R, et al. Among authors: yamamoto m. Lung Cancer. 2009 Jan;63(1):72-6. doi: 10.1016/j.lungcan.2008.04.002. Epub 2008 May 21. Lung Cancer. 2009. PMID: 18499296 Clinical Trial.
Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial.
Usami N, Yokoi K, Hasegawa Y, Taniguchi H, Shindo J, Yamamoto M, Suzuki R, Imaizumi K, Kondo M, Shimokata K; Central Japan Lung Study Group. Usami N, et al. Among authors: yamamoto m. Int J Clin Oncol. 2010 Dec;15(6):583-7. doi: 10.1007/s10147-010-0118-x. Epub 2010 Aug 17. Int J Clin Oncol. 2010. PMID: 20714770 Clinical Trial.
Phase II study of S-1 monotherapy as a first-line treatment for elderly patients with advanced nonsmall-cell lung cancer: the Central Japan Lung Study Group trial 0404.
Nishiyama O, Taniguchi H, Kondoh Y, Takada K, Baba K, Saito H, Sugino Y, Yamamoto M, Ogasawara T, Kondo M, Imaizumi K, Hasegawa Y, Suzuki R, Shimokata K; Central Japan Lung Study Group. Nishiyama O, et al. Among authors: yamamoto m. Anticancer Drugs. 2011 Sep;22(8):811-6. doi: 10.1097/CAD.0b013e3283440231. Anticancer Drugs. 2011. PMID: 21317767 Clinical Trial.
Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A, Goto Y, Fukui Y, Iwaki M, Okumura J, Yamaguchi I, Yagi T, Tanikawa Y, Sugino Y, Shindoh J, Ogasawara T, Nomura F, Saka H, Yamamoto M, Taniguchi H, Suzuki R, Saito H, Kawamura T, Hasegawa Y. Shindo Y, et al. Among authors: yamamoto m. Am J Respir Crit Care Med. 2013 Oct 15;188(8):985-95. doi: 10.1164/rccm.201301-0079OC. Am J Respir Crit Care Med. 2013. PMID: 23855620
First-line gefitinib therapy for elderly patients with non-small cell lung cancer harboring EGFR mutation: Central Japan Lung Study Group 0901.
Takahashi K, Saito H, Hasegawa Y, Ando M, Yamamoto M, Kojima E, Sugino Y, Kimura T, Nomura F, Ogasawara T, Shindoh J, Yoshida N, Suzuki R. Takahashi K, et al. Among authors: yamamoto m. Cancer Chemother Pharmacol. 2014 Oct;74(4):721-7. doi: 10.1007/s00280-014-2548-z. Epub 2014 Aug 3. Cancer Chemother Pharmacol. 2014. PMID: 25087097 Clinical Trial.
Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study.
Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Goto Y, Fukui Y, Iwaki M, Okumura J, Yamaguchi I, Yagi T, Tanikawa Y, Sugino Y, Shindoh J, Ogasawara T, Nomura F, Saka H, Yamamoto M, Taniguchi H, Suzuki R, Saito H, Kawamura T, Hasegawa Y; Central Japan Lung Study Group. Shindo Y, et al. Among authors: yamamoto m. Lancet Infect Dis. 2015 Sep;15(9):1055-1065. doi: 10.1016/S1473-3099(15)00151-6. Epub 2015 Jul 2. Lancet Infect Dis. 2015. PMID: 26145194
13,299 results
You have reached the last available page of results. Please see the User Guide for more information.